Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
10/22/2024
0:00
30:54
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
More episodes from "Radiology Podcasts | RSNA"
Don't miss an episode of “Radiology Podcasts | RSNA” and subscribe to it in the GetPodcast app.